Ionic Liquid Versus Prodrug Strategy to Address Formulation Challenges

被引:32
作者
Balk, Anja [1 ]
Widmer, Toni [1 ,2 ]
Wiest, Johannes [1 ]
Bruhn, Heike [3 ]
Rybak, Jens-Christoph [1 ]
Matthes, Philipp [4 ]
Mueller-Buschbaum, Klaus [4 ]
Sakalis, Anastasios [1 ]
Luehmann, Tessa [1 ]
Berghausen, Joerg [2 ]
Holzgrabe, Ulrike [1 ]
Galli, Bruno [2 ]
Meinel, Lorenz [1 ]
机构
[1] Univ Wurzburg, Inst Pharm, D-97074 Wurzburg, Germany
[2] Novartis Pharma AG, CH-4002 Basel, Switzerland
[3] Inst Mol Infect Biol, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Inst Inorgan Chem, D-97074 Wurzburg, Germany
关键词
active pharmaceutical ingredient; bioavailability; mechanism of supersaturation; migraine; ionic liquid; QUINAZOLINEDIONE SULFONAMIDES; DRUG DISCOVERY; NUCLEATION; PERMEABILITY; ANTAGONISTS; SOLUBILITY; ABSORPTION;
D O I
10.1007/s11095-014-1607-9
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
A poorly water soluble acidic active pharmaceutical ingredient (API) was transformed into an ionic liquid (IL) aiming at faster and higher oral availability in comparison to a prodrug. API preparations were characterized in solid state by single crystal and powder diffraction, NMR, DSC, IR and in solution by NMR and ESI-MS. Dissolution and precipitation kinetics were detailed as was the role of the counterion on API supersaturation. Transepithelial API transport through Caco-2 monolayers and counterion cytotoxicity were assessed. The mechanism leading to a 700 fold faster dissolution rate and longer duration of API supersaturation of the ionic liquid in comparison to the free acid was deciphered. Transepithelial transport was about three times higher for the IL in comparison to the prodrug when substances were applied as suspensions with the higher solubility of the IL outpacing the higher permeability of the prodrug. The counterion was nontoxic with IC50 values in the upper mu M / lower mM range in cell lines of hepatic and renal origin as well as in macrophages. The IL approach was instrumental for tuning physico-chemical API properties, while avoiding the inherent need for structural changes as required for prodrugs.
引用
收藏
页码:2154 / 2167
页数:14
相关论文
共 34 条
[1]
A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].
AHMED, SA ;
GOGAL, RM ;
WALSH, JE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224
[2]
Barbour L.J., 2001, J SUPRAMOL CHEM, V1, P189, DOI 10.1016/S1472-7862(02)00030-8
[3]
In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid [J].
Bica, Katharina ;
Rijksen, Christiaan ;
Nieuwenhuyzen, Mark ;
Rogers, Robin D. .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2010, 12 (08) :2011-2017
[4]
Nucleation of Organic CrystalsA Molecular Perspective [J].
Davey, Roger J. ;
Schroeder, Sven L. M. ;
ter Horst, Joop H. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (08) :2166-2179
[5]
OLEX2: a complete structure solution, refinement and analysis program [J].
Dolomanov, Oleg V. ;
Bourhis, Luc J. ;
Gildea, Richard J. ;
Howard, Judith A. K. ;
Puschmann, Horst .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2009, 42 :339-341
[6]
Investigation on aggregate formation of ionic liquids [J].
Dorbritz, S ;
Ruth, W ;
Kragl, U .
ADVANCED SYNTHESIS & CATALYSIS, 2005, 347 (09) :1273-1279
[7]
ACUTE DERMAL TOXICITY OF 2 QUARTERNARY ORGANOPHOSPHONIUM SALTS IN THE RABBIT [J].
DUNN, BJ ;
NICHOLS, CW ;
GAD, SC .
TOXICOLOGY, 1982, 24 (3-4) :245-250
[8]
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks [J].
Gomez-Mancilla, Baltazar ;
Brand, Ronald ;
Juergens, Tim P. ;
Goebel, Harmut ;
Sommer, Claudia ;
Straube, Andreas ;
Evers, Stefan ;
Sommer, Martin ;
Campos, Victor ;
Kalkman, Hans O. ;
Hariry, Sam ;
Pezous, Nicole ;
Johns, Donald ;
Diener, Hans-Christoph .
CEPHALALGIA, 2014, 34 (02) :103-113
[9]
Gaseous supramolecules of imidazolium ionic liquids: "Magic" numbers and intrinsic strengths of hydrogen bonds [J].
Gozzo, FC ;
Santos, LS ;
Augusti, R ;
Consorti, CS ;
Dupont, J ;
Eberlin, MN .
CHEMISTRY-A EUROPEAN JOURNAL, 2004, 10 (23) :6187-6193
[10]
The "GI dissolution" method: a low volume, in vitro apparatus for assessing the dissolution/precipitation behaviour of an active pharmaceutical ingredient under biorelevant conditions [J].
Gravestock, Tom ;
Box, Karl ;
Comer, John ;
Frake, Elizabeth ;
Judge, Sam ;
Ruiz, Rebeca .
ANALYTICAL METHODS, 2011, 3 (03) :560-567